InvestorsHub Logo
Followers 85
Posts 38723
Boards Moderated 0
Alias Born 05/09/2017

Re: None

Thursday, 01/26/2023 7:27:39 AM

Thursday, January 26, 2023 7:27:39 AM

Post# of 203
CytomX Therapeutics Announces Milestone Achievement in Probody® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTMX News